These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32132868)

  • 1. Procalcitonin: A promising tool or just another overhyped test?
    Paudel R; Dogra P; Montgomery-Yates AA; Coz Yataco A
    Int J Med Sci; 2020; 17(3):332-337. PubMed ID: 32132868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
    Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
    Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
    [No Abstract]   [Full Text] [Related]  

  • 5. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROCALCITONIN GUIDED ANTIBIOTIC STEWARDSHIP: A BALKAN EXPERT CONSENSUS STATEMENT.
    Janković R; Stojanović M; Božov H; Domi R; Ivančan V; Karišik M; Mojsova Mijovska M; Jakupović Smajić J; Šoštarič M
    Acta Clin Croat; 2023 Apr; 62(1):36-44. PubMed ID: 38304372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial.
    Euden J; Thomas-Jones E; Aston S; Brookes-Howell L; Carman J; Carrol E; Gilbert S; Howard P; Hood K; Inada-Kim M; Llewelyn M; McGill F; Milosevic S; Niessen LW; Nsutebu E; Pallmann P; Schmidt P; Taylor-Robinson D; Welters I; Todd S; French N;
    BMJ Open; 2022 Jun; 12(6):e063424. PubMed ID: 35697438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations.
    Kwa AL; Aninda Sidharta BR; Son DN; Zirpe K; Periyasamy P; Plongla R; Swaminathan S; Loho T; Van Giap V; Apisarnthanarak A
    Expert Rev Anti Infect Ther; 2024; 22(1-3):45-58. PubMed ID: 38112181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy.
    Creamer AW; Kent AE; Albur M
    Breathe (Sheff); 2019 Dec; 15(4):296-304. PubMed ID: 31803264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to best use procalcitonin to diagnose infections and manage antibiotic treatment.
    Schuetz P
    Clin Chem Lab Med; 2023 Apr; 61(5):822-828. PubMed ID: 36317790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology.
    Bassetti M; Russo A; Righi E; Dolso E; Merelli M; D'Aurizio F; Sartor A; Curcio F
    Expert Rev Anti Infect Ther; 2019 Feb; 17(2):99-105. PubMed ID: 30582713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ProCommunity: procalcitonin use in real-world US community hospital settings.
    DeSear KE; Thompson-Leduc P; Kirson N; Chritton JJ; Ie S; Van Schooneveld TC; Cheung HC; Ou S; Schuetz P
    Curr Med Res Opin; 2020 Sep; 36(9):1529-1532. PubMed ID: 32643964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
    Mewes JC; Pulia MS; Mansour MK; Broyles MR; Nguyen HB; Steuten LM
    PLoS One; 2019; 14(4):e0214222. PubMed ID: 31013271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use.
    Schuetz P; Beishuizen A; Broyles M; Ferrer R; Gavazzi G; Gluck EH; González Del Castillo J; Jensen JU; Kanizsai PL; Kwa ALH; Krueger S; Luyt CE; Oppert M; Plebani M; Shlyapnikov SA; Toccafondi G; Townsend J; Welte T; Saeed K
    Clin Chem Lab Med; 2019 Aug; 57(9):1308-1318. PubMed ID: 30721141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin: Between evidence and critical issues.
    Aloisio E; Dolci A; Panteghini M
    Clin Chim Acta; 2019 Sep; 496():7-12. PubMed ID: 31194966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
    Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
    J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
    Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
    Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
    [No Abstract]   [Full Text] [Related]  

  • 19. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.